↓ Skip to main content

The public production of medicines compared to the National Policy of Medicines and the burden of disease in Brazil

Overview of attention for article published in Cadernos de Saúde Pública, September 2017
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The public production of medicines compared to the National Policy of Medicines and the burden of disease in Brazil
Published in
Cadernos de Saúde Pública, September 2017
DOI 10.1590/0102-311x00179815
Pubmed ID
Authors

Tatiana Aragão Figueiredo, Joyce Mendes de Andrade Schramm, Vera Lúcia Edais Pepe

Abstract

: The public production of medicines in Brazil by Government Pharmaceutical Laboratories has once again become the object of incentives, and Industrial Development Partnerships are one of the mechanisms adopted for the production of strategic medicines for the Brazilian Unified National Health System (SUS). Considering that burden-of-disease studies have been used as a tool to define priority and essential medicines, the article compares the product portfolios of the country's Official Pharmaceutical Laboratories (OPL) and the list of strategic medicines for the SUS and burden of disease in Brazil in 2008. Of the 205 strategic medicines for the SUS and 111 from the portfolios, 73% and 89%, respectively, are on the National List of Essential Medicines (RENAME 2014). Some strategic medicines for the SUS are already produced by OPL and feature the selection of cancer drugs and biologicals. The current study contributes to the discussion on the public production of medicines in light of the country's current industrial policy and highlights the need to define priority drugs and the role of OPL in guaranteeing access to them.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 4%
Lecturer > Senior Lecturer 1 4%
Student > Doctoral Student 1 4%
Student > Bachelor 1 4%
Researcher 1 4%
Other 1 4%
Unknown 17 74%
Readers by discipline Count As %
Economics, Econometrics and Finance 2 9%
Nursing and Health Professions 1 4%
Unspecified 1 4%
Business, Management and Accounting 1 4%
Social Sciences 1 4%
Other 0 0%
Unknown 17 74%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2017.
All research outputs
#22,764,772
of 25,382,440 outputs
Outputs from Cadernos de Saúde Pública
#1,564
of 1,854 outputs
Outputs of similar age
#289,102
of 328,838 outputs
Outputs of similar age from Cadernos de Saúde Pública
#34
of 39 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,854 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,838 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.